Journal of Ovarian Research

Article	Citations
Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review	119
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective	73
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases	63
The role of oxidative stress in ovarian aging: a review	55
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells	51
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age	49
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment	49
Withaferin A: a potential therapeutic agent against COVID-19 infection	45
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis	39
Therapeutic role of curcumin and its novel formulations in gynecological cancers	37
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer	36
Long non-coding RNAs in ovarian granulosa cells	35
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized	35
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis	35
An overview of FSH-FSHR biology and explaining the existing conundrums	35
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis	33
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses	33
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer	32
Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention	32
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells	32
Anti-tumor activities of probiotics in cervical cancer	32
Adipocytes: active facilitators in epithelial ovarian cancer progression?	31
Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway	31
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS	31
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis	31

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells	30
Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review	30
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer	29
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A	28
Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models	27
LINC01094/miR-577 axis regulates the progression of ovarian cancer	26
Targeting purine metabolism in ovarian cancer	25
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging	25
Association between morphologic grading and implantation rate of Euploid blastocyst	25
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients	24
Comparison of methods for quantifying primordial follicles in the mouse ovary	24
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis	24
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis	24
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1	23
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population	23
Prediction of the treatment response in ovarian cancer: a ctDNA approach	21
Transcriptomics of cumulus cells – a window into oocyte maturation in humans	21
Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1	21
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study	21
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells	20
RETRACTED ARTICLE: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis	20
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer	19
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients	19
Telomere length in granulosa cells and leukocytes: a potential marker of female fertility? A systematic review of the literature	19
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats	18
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression	18
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses	18
MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4	18
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice	18
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcino	18
Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome	17
Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments	17
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis	17
CACNA1C is a prognostic predictor for patients with ovarian cancer	17
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p	16
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma	16
Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis	16
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?	16
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors	16
Mechanisms of ovarian aging in women: a review	16
RETRACTED ARTICLE: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression	16
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer	16
Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer	16
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?	16
p38β - MAPK11 and its role in female cancers	15
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer	15
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway	15
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer	15
Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders	15
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis	15

Role of different non-coding RNAs as ovarian cancer biomarkers	15
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer	15
The role of MMP-14 in ovarian cancer: a systematic review	15
Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR	15
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer	15
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy	14
Mutation analysis of the TUBB8 gene in primary infertile women with oocyte maturation arrest	14
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?	14
Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression	14
Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway	14
LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS	14
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients	14
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis	14
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications	14
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer	14
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study	13
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature	13
BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea	13
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer	13
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles	13
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells	13
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3	13
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer	13
Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors	13
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review	13
The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model	13
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism	13
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer	13
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer	12
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients	12
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA	12
LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation	12
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing	12
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer	12
Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K	12
RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration	12
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway	12
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study	12
Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer	11
miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B	11
A risk model of gene signatures for predicting platinum response and survival in ovarian cancer	11
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer	11
miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9	11
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients	11
MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4	11
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis	11
Association between atypical endometriosis and ovarian malignancies in the real world	11
Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis	11
LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation	11
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer	11
Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome	11
Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma	10
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience	10
Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI	10
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review	10
Effect of blastocyst morphology and developmental speed on transfer strategy for grade “C” blastocyst in vitrified‐warmed cycles	10
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer	10
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics	10
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling	10
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching	10
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report	10
Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway	10
Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer	10
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4	10
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture	10
Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study	10
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network	10
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status	10
Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes	10
The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p	10
Ovarian microcystic stromal tumor with omental metastasis: the first case report and literature review	10
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway	10
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer	10
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer	10
Effects of the sperm DNA fragmentation index on the clinical and neonatal outcomes of intracytoplasmic sperm injection cycles	10
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro	10
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer	9
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome	9
A flexible short protocol in women with poor ovarian response over 40 years old	9
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization	9

Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis	9
Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro	9
Predictive factors of endometriosis progression into ovarian cancer	9
Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature	9
Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis	9
Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome	9
Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer	9
WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells	9
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia	9
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells	9
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer	9
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer	9
Lnc-GULP1–2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization	9
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation	9
Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer	8
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors	8
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer	8
Laser-assisted hatching in lower grade cleavage stage embryos improves blastocyst formation: results from a retrospective study	8
Fertility care amidst the COVID19 pandemic: the American experience	8
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer	8
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6	8
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles	8
Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China	8
Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice	8
Troxerutin protects against DHT-induced polycystic ovary syndrome in rats	8
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3	8
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer	8
The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve	8
Plumbagin rescues the granulosa cell’s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome	8
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis	8
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer	8
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6	8
Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-β/Smads signaling pathway	8
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes	8
Small RNA sequencing reveals distinct nuclear microRNAs in pig granulosa cells during ovarian follicle growth	8
The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas	8
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis	8
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors	8
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors	8
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy	8
Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey	8
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present	8
GIMAP7 induces oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inhibiting sonic hedgehog signalling pathway	8
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics	8
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway	8
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq	8
Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats	8